Tapentadol for the management of cancer pain in adults: an update
(2023)
Journal Article
Boland, J. W. (2023). Tapentadol for the management of cancer pain in adults: an update. Current opinion in supportive and palliative care, 17(2), 90-97. https://doi.org/10.1097/SPC.0000000000000641
PURPOSE OF REVIEW: Tapentadol is the first of a new class of analgesics, having synergistic µ-opioid receptor agonist and noradrenaline reuptake inhibitory actions. It has been widely researched in many areas of pain, often in noninferiority studies... Read More about Tapentadol for the management of cancer pain in adults: an update.